Alaska Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• Discontinuation of Anticoagulation Following Catheter Ablation of AF: Updates With OCEAN Trial
  Current guidelines for management of atrial fibrillation (AF) recommend continuation of oral anticoagulation (OAC) following successful catheter ablation of AF for patients deemed at elevated thromboembolic risk.
• Novel Sarcopenic Obesity Index Predicts CV Risk
  A novel sarcopenic obesity index served as a clinically meaningful predictor of cardiovascular risk and lent further insight into accompanying genetics and possible therapeutic targets, according to research published July 1 in JACC.
• Poll Results: Brainstorm: Restarting Anticoagulation After Brain Bleed
  This poll included a clinical vignette of an 80-year-old man with atrial fibrillation (AF), high thromboembolic risk, and multiple cardiovascular (CV) comorbidities who presented 2 months after a spontaneous lobar intracerebral hemorrhage while receiving reduced-dose apixaban...
• Eagle’s Eye View: Clopidogrel vs. Aspirin Following PCI
  In this week’s View, Dr. Eagle looks at how genotype independently predicts heart failure outcomes in patients with hypertrophic cardiomyopathy (HCM).
• Guest Editorial | Turning Prevention Into Practice: ACC's Coordinated Approach
  The ACC's work in cardiovascular disease (CVD) prevention is entering an important new phase – one that reflects both the urgency of the challenge and the opportunity to deliver lasting impact.